Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Accepted on 14 Aug 2025

Nasal cells as a bronchial cell surrogate for pre-clinical assessment of drug response in cystic fibrosis

in Respiratory Pharmacology

Malina Barillaro
Julie Avolio
Sharaniyaa Balachandran
Claire Bartlett
Wan Ip
Hong Ouyang
Wenming Duan
Joseph Zabner
Shaf Keshavjee
Christine E. Bear

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1651122

113 views

Original Research

Published on 14 Aug 2025

Active surveillance of adverse drug events in hospitalized patients with pulmonary arterial hypertension based on the global trigger tool

in Respiratory Pharmacology

Mengdan Xu
Shunyu Xiong
Guanquan Chen
Guozhi Li
Suzhen He

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533634

365 views

Review

Published on 13 Aug 2025

Unlocking the secrets of glucose metabolism reprogramming: the role in pulmonary diseases

in Respiratory Pharmacology

Zhen Li
Shuo-Xuan Chen
Shuai Jiang
Yi-Nong Yang
Xi-Chan Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551452

237 views

Review

Accepted on 12 Aug 2025

Dipeptidyl Peptidase 1 Inhibitors for Inflammatory Respiratory Diseases: Mechanisms, Clinical Trials, and Therapeutic Prospects

in Respiratory Pharmacology

Dandan ZHANG
Wenwen Zhang
Ping Hu
Wei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1656316

419 views

Original Research

Accepted on 12 Aug 2025

Association Between Acetaminophen Use and 30-Day Mortality in Critically Ill Patients with Pulmonary Embolism: A Retrospective Cohort Study Using the MIMIC-IV Database

in Respiratory Pharmacology

Liman Qiu
Xiankun Lin
Xunwei Tu
Linqian Jiang
Xiuling Shang
Xincai Wang
Long Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1663773

Original Research

Accepted on 11 Aug 2025

Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy

in Respiratory Pharmacology

Ben Wang
Xueling Wu
Yu Zhong
Chaowang Huang
Zhi Xu
Liang Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1552034

100 views

Review

Published on 08 Aug 2025

Efficacy and safety of reduning injection for severe pneumonia: a systematic review and meta-analysis

in Respiratory Pharmacology

Yan Wang
Baichuan Xu
Peng Zhang
Suyun Li
Yang Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1591136

569 views

Original Research

Published on 08 Aug 2025

The first step for understanding the molecular mechanism of the antifibrotic effect of inhaling 25(OH)-vitamin D3 and 1,25(OH)2-vitamin D3 in the murine model of hypersensitivity pneumonitis

in Respiratory Pharmacology

Marta Kinga Lemieszek
Michał Chojnacki
Iwona Paśnik
Alicja Wilczyńska
Wiktoria Gawryś
Jakub Anisiewicz
Ilona Leśniowska
Michał Kiełbus

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1610165

342 views

Correction

Published on 07 Aug 2025

Correction: Novel mitophagy inducer TJ0113 alleviates pulmonary inflammation during acute lung injury

in Respiratory Pharmacology

Zhengyuan Liu
Danruo Fang
Kaijun Chen
Lingling Dong
Huaqiong Huang
Zhihua Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1667879

233 views

Case Report

Published on 06 Aug 2025

NTRK1-fusion as an acquired resistance mechanism in EGFRex19 mutated NSCLC: a case report

in Respiratory Pharmacology

Jielin Li
Yunyun Shi
Mengge Zheng
Chenkang Yang
Hong Gao
Xiaoling Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571777

593 views

Review

Published on 31 Jul 2025

Gut-lung axis in allergic asthma: microbiota-driven immune dysregulation and therapeutic strategies

in Respiratory Pharmacology

Jian Lv
Yu Zhang
Shuang Liu
Ruoyu Wang
Jianan Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1617546

541 views

Original Research

Published on 30 Jul 2025

Quercetin ameliorates epithelial-mesenchymal transition and inflammation by targeting FSTL1 and modulating the NF-κB pathway in pulmonary fibrosis

in Respiratory Pharmacology

Yuejiao Lan
Cuiting Dong
Mingda Wu
Ruichen Yuan
Kunpeng Yang
Zhen Yang
Yang Chen
Jingbin Zhang
Bingxue Qi
Xiaodan Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1594757

724 views

Original Research

Accepted on 25 Jul 2025

Optimization of Ivacaftor-loaded Solid Lipid Nanoparticles for Solubility Enhancement

in Respiratory Pharmacology

Akshay Parihar
Bhupendra Gopalbhai Prajapati
Himanshu Paliwal

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1619481

241 views

Clinical Trial

Published on 25 Jul 2025

Comparison of pharmacokinetic similarity, immunogenicity, and safety of mepolizumab and BAT2606 in healthy Chinese men in a double-blinded, randomized, single-dose, three-arm parallel-group phase I trial

in Respiratory Pharmacology

Cuiyun Li
Jixuan Sun
Jia Xu
Min Wu
Xiaojiao Li
Zhijie Liu
Qingfeng Dong
Yu Sun
Yanhua Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1580883

550 views

Original Research

Published on 23 Jul 2025

The effects of benralizumab on lung volume changes during exercise in experimental setting in severe asthmatics: a pilot study

in Respiratory Pharmacology

Alida Benfante
Alessandra Tomasello
Lorena Gentile
Alessia Leonarda Lisotta
Paola Marasà
Salvatore Battaglia
Nicola Scichilone

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1611168

605 views

Review

Published on 16 Jul 2025

Mapping the oxidative landscape in cystic fibrosis: methodological frontiers and application

in Respiratory Pharmacology

Michela Rubin
Ilaria Artusi
Giorgio Cozza

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1632924

1,119 views